ARCHIVES

FDA Committee nixes Combination Guidelines, Okays New NDA Policy

This article is from The Cancer Letter archive.

Vol. 03 No. 03 | January 21, 1977

Download PDF Visit The Full Archive

Related Articles

Sebelius: Congress Harming Nation’s Investment in Science

October 4, 2013

ORI Whistle-Blower Proposal Too Rigid, Biologists Say.

February 2, 2001

GAO Report: Taxol CRADA “Successful,” But Not Great Financial Deal.

June 27, 2003

NCI Amends FCRF RFP, Extends Deadline To Nov. 10

August 22, 1986

O’Shaughnessy, Burris To Present for Genentech At FDA Hearing At June 28-29

June 10, 2011

In Brief: General Motors Cancer Prizes Awarded; Thomas Promoted; HIV Research funding

June 24, 1994